Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Segura

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Neurochemistry International|March 30, 2019
The importance of choosing a preclinical model that reflects what happens in Parkinson's diseaseJuan Segura-Aguilar
Neurotoxicity Research|January 10, 2018
Neurotoxins as Preclinical Models for Parkinson's DiseaseJuan Segura-Aguilar
Neural Regeneration Research|August 2, 2017
On the role of endogenous neurotoxins and neuroprotection in Parkinson's diseaseJuan Segura-Aguilar
Mathematical Biosciences|May 10, 2024
One way or another: Combined effect of dispersal and asymmetry on total realized asymptotic population abundanceJuan Segura, Daniel Franco
Biomolecules|June 27, 2024
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration ModelSandro Huenchuguala, Juan Segura-Aguilar
Biomedicines|November 25, 2023
On the Role of Iron in Idiopathic Parkinson's DiseaseSandro Huenchuguala, Juan Segura-Aguilar
Nutrients|November 13, 2025
A Potential Role of Natural Bioactive Compounds Found in Food in the Prevention of Idiopathic Parkinson's DiseaseSandro Huenchuguala, Juan Segura-Aguilar
Neural Regeneration Research|September 18, 2023
Single-neuron neurodegeneration as a degenerative model for Parkinson's diseaseSandro Huenchuguala, Juan Segura-Aguilar
Antioxidants (Basel, Switzerland)|March 29, 2023
A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant TherapiesJuan Segura-Aguilar, Bengt Mannervik
Antioxidants (Basel, Switzerland)|September 28, 2024
Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's DiseaseSandro Huenchuguala, Juan Segura-Aguilar
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Neurochemistry International|March 30, 2019
The importance of choosing a preclinical model that reflects what happens in Parkinson's diseaseJuan Segura-Aguilar
Neurotoxicity Research|January 10, 2018
Neurotoxins as Preclinical Models for Parkinson's DiseaseJuan Segura-Aguilar
Neural Regeneration Research|August 2, 2017
On the role of endogenous neurotoxins and neuroprotection in Parkinson's diseaseJuan Segura-Aguilar
Mathematical Biosciences|May 10, 2024
One way or another: Combined effect of dispersal and asymmetry on total realized asymptotic population abundanceJuan Segura, Daniel Franco
Biomolecules|June 27, 2024
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration ModelSandro Huenchuguala, Juan Segura-Aguilar
Biomedicines|November 25, 2023
On the Role of Iron in Idiopathic Parkinson's DiseaseSandro Huenchuguala, Juan Segura-Aguilar
Nutrients|November 13, 2025
A Potential Role of Natural Bioactive Compounds Found in Food in the Prevention of Idiopathic Parkinson's DiseaseSandro Huenchuguala, Juan Segura-Aguilar
Neural Regeneration Research|September 18, 2023
Single-neuron neurodegeneration as a degenerative model for Parkinson's diseaseSandro Huenchuguala, Juan Segura-Aguilar
Antioxidants (Basel, Switzerland)|March 29, 2023
A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant TherapiesJuan Segura-Aguilar, Bengt Mannervik
Antioxidants (Basel, Switzerland)|September 28, 2024
Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's DiseaseSandro Huenchuguala, Juan Segura-Aguilar
Pageof 13